The Nervous System
Dysautonomia, POTS, long COVID, heart rate variability, vagal tone — and why caffeine is one of the most contested substances in autonomic medicine. The final and most complex piece of the picture.
Written for anyone who has a condition affecting their autonomic nervous system — POTS, dysautonomia, long COVID, chronic fatigue — and is trying to work out whether coffee is helping or making things worse. The answer is genuinely complicated, and this section does not pretend otherwise.
The system that runs everything you do not have to think about
Your autonomic nervous system controls the things your body does automatically — heart rate, blood pressure, breathing, digestion, temperature regulation, the constriction and dilation of blood vessels. It operates through two branches that need to balance each other: the sympathetic system, which mobilises you for action, and the parasympathetic system, which brings you back to rest and recovery.
Caffeine pushes directly on this balance. It stimulates the sympathetic branch — increasing heart rate, elevating blood pressure, and constricting certain blood vessels. For most people with a normally functioning autonomic nervous system, this is manageable and largely positive at moderate doses. For people with dysautonomia — where the autonomic system is already dysregulated — the picture is considerably more complicated.
Dysautonomia is not a single condition. It is an umbrella term for any dysfunction of the autonomic nervous system. The most common form encountered in clinical practice is POTS — postural orthostatic tachycardia syndrome — where the heart rate rises excessively when moving from lying to standing. Others include orthostatic hypotension, vasovagal syncope, and the broader autonomic dysfunction seen in long COVID and conditions like Ehlers-Danlos syndrome.
Dysautonomia often overlaps with MCAS (Section 08), ADHD, hypermobile connective tissue disorders, and chronic fatigue syndrome. If you have one of these conditions, the chances of having elements of autonomic dysfunction are meaningfully elevated.
The condition where caffeine may both help and harm simultaneously
POTS is the clearest example of caffeine's contradictory effects in autonomic dysfunction. Caffeine constricts blood vessels and raises blood pressure — effects that may temporarily improve orthostatic tolerance, reducing the dizziness and light-headedness that characterise POTS on standing.
But caffeine is also a diuretic at higher doses, reducing blood volume — exactly the opposite of what POTS management requires. And if MCAS is present alongside POTS (which it often is), caffeine's mast cell activation effects can directly worsen dysautonomia symptoms. Whether caffeine helps or harms a specific individual with POTS depends on which of these mechanisms is dominant in their particular presentation.
When standing up is the problem
POTS is characterised by an excessive heart rate increase on moving from lying to standing — 30 beats per minute or more in adults. Caffeine's vasoconstrictive effects may transiently reduce the pooling that drives this, which is why some POTS patients report that morning coffee genuinely helps them function.
But this benefit is subtype-dependent. In hyperadrenergic POTS — where the problem is already an overactivated sympathetic system — caffeine's sympathomimetic effects add fuel to an already burning fire. Subtype matters before any guidance is given.
Caffeine is not straightforwardly good or bad for dysautonomia. It is a substance that pushes on multiple mechanisms simultaneously, some helpful and some harmful, in proportions that vary between individuals.
The emerging picture in post-viral autonomic dysfunction
Post-COVID dysautonomia is one of the most common presentations of long COVID, affecting a substantial proportion of patients with persistent symptoms. The autonomic dysfunction in long COVID appears to involve a combination of small fibre neuropathy, mast cell activation, and direct autoimmune effects on autonomic ganglia.
For long COVID patients, caffeine presents the same dilemma as in primary dysautonomia — the vasoconstrictive and sympathomimetic effects may temporarily improve some symptoms while the stimulant load and mast cell activation worsen others. The most common clinical observation is that long COVID patients who previously tolerated coffee well find that the same intake now produces palpitations, worsened fatigue, or heightened anxiety that persists for hours. This is not primarily a caffeine sensitivity issue — it reflects a changed autonomic landscape in which the same caffeine input produces different outputs.
Start from scratch. Your pre-COVID caffeine tolerance is no longer a reliable guide. Reduce to half your previous intake and observe carefully for 2 weeks. Pay particular attention to post-exertional symptoms — the worsening of fatigue and cognitive symptoms that occurs in the hours or days after exertion is a hallmark of long COVID, and caffeine's stimulant effects may mask the early signals that would otherwise tell you to rest.
If palpitations, chest tightness, or significant worsening of fatigue occur with any caffeine, stop entirely and raise this with your clinical team. These symptoms warrant investigation in the long COVID context and should not be managed by trial and error alone.
What wearables can tell you — and what they cannot
Heart rate variability — HRV — is the variation in time between successive heartbeats. Higher HRV generally reflects a healthier, more responsive autonomic nervous system with strong vagal tone. Lower HRV is associated with stress, poor sleep, overtraining, and illness.
Caffeine acutely reduces HRV through sympathetic activation — it raises heart rate and reduces the variability that reflects parasympathetic influence. If you track HRV with a wearable and notice that it is consistently lower on high-caffeine days, that is not a quirk of the measurement. It is a real physiological effect that is worth taking seriously as a personalised feedback signal about how your autonomic system is responding to your intake.
If you use a device that tracks HRV, try the following experiment over 4 weeks: for 2 weeks, track your HRV on days of normal caffeine intake. For the following 2 weeks, keep everything else identical but reduce intake by half or shift all caffeine to before 10am. The difference in your average HRV score is your personal autonomic caffeine signal — more useful than any population average.
Covers autonomic nervous system physiology and caffeine's sympathomimetic mechanisms, POTS pathophysiology and the conflicting evidence for caffeine in orthostatically impaired patients, long COVID dysautonomia mechanisms, HRV as a caffeine biomarker, orthostatic hypotension considerations, and the MCAS-dysautonomia combined presentation.
Caffeine's sympathomimetic mechanisms
Caffeine's effects on the autonomic nervous system operate through both central and peripheral mechanisms. Centrally, adenosine A1 receptor blockade in the brainstem cardiovascular control centres — particularly the nucleus tractus solitarius and the rostral ventrolateral medulla — disinhibits sympathetic outflow, producing tachycardia, increased cardiac contractility, and peripheral vasoconstriction. Peripherally, caffeine's methylxanthine structure inhibits phosphodiesterase activity, increasing intracellular cAMP and potentiating the effects of circulating catecholamines on cardiovascular tissues.
The net haemodynamic effect is a transient increase in heart rate and blood pressure that is most pronounced in caffeine-naive individuals and largely attenuated in habitual users through tolerance mechanisms. Heart rate variability — the beat-to-beat variability reflecting parasympathetic modulation of the sinoatrial node — is acutely reduced by caffeine through its relative enhancement of sympathetic tone. The reduction in HRV magnitude correlates with caffeine dose and is modifiable by L-theanine co-administration (Section 04).
The conflicting evidence — a mechanistic account
POTS is characterised by an excessive heart rate increment of 30 bpm or more (40 bpm in patients aged under 19) on moving from supine to standing, in the absence of orthostatic hypotension. The pathophysiology is heterogeneous, with multiple subtypes including hyperadrenergic POTS (elevated noradrenaline on standing), neuropathic POTS (partial sympathetic denervation of the lower limbs), hypovolaemic POTS, and autoimmune POTS associated with adrenergic receptor autoantibodies.
Caffeine's theoretical benefits in POTS derive from its vasoconstrictive effects — peripheral vasoconstriction reduces venous pooling in the lower limbs, which is a central mechanism in neuropathic and hypovolaemic POTS subtypes. The sympathomimetic effects may also acutely raise blood pressure to improve orthostatic tolerance. In clinical practice, some POTS patients empirically report improved orthostatic symptoms from morning caffeine, and anecdotally incorporate it into their symptom management alongside increased fluid and salt intake.
In the hyperadrenergic POTS subtype, characterised by elevated standing noradrenaline above 600pg/ml and disproportionate sympathetic activation on standing, caffeine's sympathomimetic effects are additive to an already hyperactivated sympathetic state. These patients typically experience worsening palpitations, anxiety, and headache with caffeine. Caffeine is contraindicated in hyperadrenergic POTS in all but the smallest doses.
POTS subtype is clinically relevant to caffeine guidance and should be established before advising patients with POTS about caffeine use. In the absence of subtype information, conservative restriction is the appropriate default.
Mechanistic basis and clinical management
Post-COVID dysautonomia involves multiple converging mechanisms: small fibre neuropathy confirmed on skin punch biopsy in a significant proportion of patients with dysautonomic symptoms; autoimmune adrenergic and muscarinic receptor autoantibodies (Wallukat et al., 2021; Gunning et al., 2021); persistent mast cell activation driven by viral antigen persistence or immune dysregulation; and direct effects of spike protein on autonomic ganglia and the endothelium.
Caffeine in this context acts on an autonomic system that is simultaneously hyperactivated (by persistent sympathetic excess) and depleted (by reduced parasympathetic tone and impaired cardiac baroreflex). The stimulant load from caffeine is processed differently in this landscape — the normal sympathetic dampening mechanisms are less effective, and the effects on heart rate and vascular tone may be disproportionate. This explains the clinical observation that long COVID patients who previously consumed caffeine without difficulty often experience significant palpitations, chest tightness, or post-exertional malaise worsening from the same intake post-infection.
Heart rate variability and personalised caffeine assessment
HRV measurement offers a practical, individualisable biomarker for assessing autonomic caffeine response in clinical populations. Reduced HRV reflects relative sympathetic dominance and impaired parasympathetic modulation. Caffeine's acute HRV-reducing effects are dose-dependent and partially attenuated by L-theanine co-administration. In patients with dysautonomia, anxiety disorders, or post-COVID syndrome, serial HRV monitoring across different caffeine intake conditions provides an objective, patient-generated dataset that complements clinical history.
The practical protocol is straightforward: morning resting HRV measurement before any caffeine, tracked consistently over 4 to 8 weeks across varying intake conditions. Within-person variation is the signal — between-person comparisons are less relevant. Devices such as the Oura Ring, Garmin, Apple Watch, and dedicated HRV applications provide sufficient measurement accuracy for clinical monitoring purposes, though no device provides research-grade ECG accuracy.
High vagal tone — reflected in elevated HRV — is one of the strongest predictors of cardiovascular resilience, stress recovery capacity, and cognitive flexibility across the lifespan. The evidence that habitual high caffeine intake suppresses resting HRV in susceptible individuals, even after tolerance develops to the acute haemodynamic effects, represents a plausible pathway through which chronic high caffeine use may reduce long-term autonomic resilience.
This is not an argument for caffeine elimination. It is an argument for the individualised, informed approach that this entire guide has been building toward: understanding the full biological picture well enough to make decisions that serve the specific person in front of you.
A specific high-risk population
Orthostatic hypotension — a sustained systolic BP drop of 20 mmHg or diastolic drop of 10 mmHg within 3 minutes of standing — represents a specific population where caffeine advice requires particular care. While caffeine's acute vasopressor effects may transiently improve orthostatic tolerance in the short term, several antihistamines, TCAs, alpha-blockers, and antihypertensives used in the management of orthostatic hypotension interact with caffeine's cardiovascular effects in ways that are not well characterised in the literature.
Additionally, post-prandial hypotension — a significant BP drop following meals, affecting up to 30% of older adults — is worsened by caffeine's effects on gut blood flow and vasomotor regulation. The traditional practice of drinking coffee or tea with meals, particularly in older patients with autonomic impairment, warrants clinical review. The evidence does not support caffeine as a reliable orthostatic hypotension management strategy, and the risks of uncontrolled pharmacological interaction in polypharmacy populations are meaningful.
Caffeine's effects in dysautonomia are mechanistically contradictory. Vasoconstrictive effects may improve orthostatic tolerance in neuropathic and hypovolaemic POTS subtypes. The same properties worsen hyperadrenergic POTS. Subtype matters and should inform guidance.
Long COVID patients should reassess caffeine tolerance from baseline. Post-viral autonomic dysfunction creates a changed landscape in which pre-infection caffeine tolerance is unreliable. Palpitations or worsening post-exertional malaise from caffeine warrant clinical investigation.
HRV monitoring provides a practical individualisable biomarker for autonomic caffeine response. Morning resting HRV tracked across varying caffeine intake conditions over 4 to 8 weeks offers clinically useful within-person data in dysautonomia, anxiety disorders, and post-COVID syndrome.
The MCAS-dysautonomia overlap is clinically significant. Mast cell-mediated autonomic sensitisation and histamine-driven vascular instability link the two conditions. In combined presentations, caffeine's dual role as mast cell activator and sympathomimetic requires an individualised assessment that considers both pathways.
Post-prandial hypotension in older adults is worsened by caffeine. The practice of drinking coffee or tea with meals in patients with autonomic impairment or polypharmacy warrants review. Caffeine should not be relied upon as an orthostatic hypotension management strategy.
You have reached the end of The Informed Cup. Across these nine sections, we have covered what caffeine actually does — in your brain, your stress system, your sleep architecture, your hormones, your body, your immune system, and your autonomic nervous system. The aim was not to make you stop drinking coffee. It was to give you a complete enough picture that you can use it intelligently, on your own terms.
Everything in this guide is general information. If something you have read has raised a question about your own health — your caffeine sensitivity, your sleep, your hormones, a possible ADHD or autism diagnosis, or something you have noticed about how your brain and body work — we can help you understand it in a personal clinical context.
Complete our short referral form at sanctumhealthcare.co.uk. No GP referral required.
A clinical assessment with one of our team to understand your situation and what help would be appropriate.
Comprehensive neurodevelopmental assessment for ADHD, autism, or combined presentations across the lifespan.
Treatment, medication management, and clinical support for as long as it is useful to you.
POTS, dysautonomia, long COVID, and HRV all change the risk-benefit calculation for caffeine. Get a protocol that factors in your autonomic profile.
Caffeine content by drink, acidity, and preparation method are all variables worth understanding for nervous system profiles.
